Boulder, CO · Founded 2019 · Privately Held (backing)
Developer of antibody-based therapeutics designed for enhanced drug delivery in oncology. BioLoomics is based in Boulder, CO and was founded in 2019. Its last reported valuation was $22.4 million in Mar 2023. It has raised $10.4 million across 4 recorded rounds; the latest was a $450,000 seed round in Aug 2025.
Last reported valuation
$22.4M
Oct 2026
Priced at
—
Total raised
$10.4M
Last round
Seed Round
Aug 2025
Team — not yet on record
No current team members for BioLoomics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioLoomics with a free account
·The complete investor list: 12 names
·Watch BioLoomics: the Monday email on marks, rounds and moves
